Kyushu Hematology Organization for Treatment Study Group : Phase I study of thecombination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma.
書誌事項
- タイトル
- Kyushu Hematology Organization for Treatment Study Group : Phase I study of thecombination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma.
- 著者
- Suzumiya J, Suzushima H, Maeda K, Okamura S, Utsunomiya A, Shibuya T, Tamura K
収録刊行物
-
- Int J Hematol 79
-
Int J Hematol 79 266-270, 2004
- Tweet
詳細情報
-
- CRID
- 1010282256791332509
-
- 資料種別
- journal article
-
- データソース種別
-
- KAKEN